Qi Zhao

39PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPeriodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 20, 2026
Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study.

|Sep 02, 2026
Vitamin B5 supports anti-PD1 response in HER2-positive gastric cancer and enhances interaction between naïve B cells and T cells.

|Mar 02, 2026
Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study).

Yi-Chen Yao, Ming-Ming He, Min Wang

|Jun 02, 2025
Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors.

Min Wang, Yanxing Chen, Lin Tian

|Mar 15, 2025
Deep learning prioritizes cancer mutations that alter protein nucleocytoplasmic shuttling to drive tumorigenesis.

Yongqiang Zheng, Kai Yu, Jin-Fei Lin

|Sep 28, 2024
Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny.

Shensuo Li, Yuzhong Peng, Minjun Chen

Pageof 7

Frequent Collaborators

19 joint publications

Rui-Hua Xu

15 joint publications

Zexian Liu

9 joint publications

Zhixiang Zuo

9 joint publications

Feng Wang